SION
Sionna Therapeutics, Inc. NASDAQ Listed Feb 7, 2025$43.24
Mkt Cap $1.9B
52w Low $11.77
90.7% of range
52w High $46.46
50d MA $38.47
200d MA $34.42
P/E (TTM)
-20.8x
EV/EBITDA
-18.0x
P/B
5.1x
Debt/Equity
0.0x
ROE
-24.5%
P/FCF
-24.7x
RSI (14)
—
ATR (14)
—
Beta
3.01
50d MA
$38.47
200d MA
$34.42
Avg Volume
356.8K
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
CIK (SEC)
Phone
617 819 2020
21 Hickory Drive Suite 500 · Waltham, MA 02451 · US
Data updated apr 27, 2026 1:21am
· Source: massive.com